| PEMOE40 | The effects of COVID-19 on HIV care and treatment programs: a multicountry review | Poster exhibition | Impact of COVID-19 on HIV treatment services |
| EPD126 | The effects of HIV-related structural discrimination on mental health outcomes for trans women, San Francisco | E-poster | Transgender people |
| EPF094 | The effects of structural racism and discrimination on HIV health outcomes: a systematic review | E-poster | Racism and other forms of ethnicity-based social exclusion |
| OAD0104 | The efficiency of index contact testing approach in community HIV case identification | Oral abstract session with live Q&A | Community mobilization and demand creation |
| EPF026 | The end of patent term extensions in Brazil: positive impacts for the procurement of ARVs | E-poster | Laws and policies regulating access to drugs and medical devices (including intellectual property and trade regimes, competition law and price regulation) |
| OAB0202 | The fast and the continuous: dolutegravir-based antiretroviral therapy achieves impressive viral load suppression in CALHIV in the short- and long-term | Oral abstract session with live Q&A | ARV management strategies in paediatric and adolescent populations |
| EPD259 | The feasibility and acceptability of engaging the brothers and sisters of Latinx gay men (LGM) to promote PrEP use | E-poster | Couples- or family-centred approaches |
| EPC394 | The feasibility and acceptability of prison-based voluntary assisted partner notification among incarcerated men with HIV and their community partners | E-poster | HIV testing to support identification of new cases of people living with HIV |
| PESAE02 | The fidelity of a pharmacy-based PrEP delivery model in Kenya: an unannounced standardized patient actor assessment | Poster exhibition | Implementation science of scaling up prevention (including PrEP) |
| EPE275 | The final stages of an epidemic? Learning from London's community-led HIV response | E-poster | Community participation in systems for health, including community-led and key population-led health systems |